Clinical Phase II Study of Pegylated Liposomal Doxorubicin...

Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma

Fink, W., Zimpfer-Rechner, C., Thoelke, A., Figl, R., Kaatz, M., Ugurel, MS., Schadendorf, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Year:
2004
Journal:
Onkologie
DOI:
10.1159/000081335
File:
PDF, 68 KB
2004
Conversion to is in progress
Conversion to is failed